🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Our new study Ömer Dizdar Deniz Can Guven Mert TOKATLI Taha Koray Sahin ✨️✨️✨️ Prognostic value of serum albumin-creatinine ratio as a biomarker in patients treated with immune checkpoint inhibitors: Immunotherapy tandfonline.com/doi/full/10.10…

Huge congrats to rising stars of Hacettepe Üniversitesi oncology 👏👏👏👏 Sky is the limit for Taha Koray Sahin and Onur Baş, MD 🧿🧿🧿🧿

Big news from nature 🔍 Transparent peer review is now standard for all research papers. Referee reports + author replies will be published with each article. More clarity. More trust. More accountability. How do you think this will affect science? #Science #PeerReview

T-DXd has shown tremendous activity in trials. But how does it perform in the real world? What is its activity in pts with BRCA+, PDL1+ dz, or prior SG? We joined forces with Yale University to address this question in one of the largest studies to date (n=~1500).🧵 esmoopen.com/article/S2059-…

🚨 Just out in Red Journal! We analyzed our 191-patient H&N reirradiation cohort, with a specific focus on toxicity and CBOS 📊 Real-world SBRT data 🧑‍⚕️ Lessons on patient selection & risk mitigation redjournal.org/article/S0360-… IJROBP - The Red Journal Gozde Yazici Alper Kahvecioglu MD Ecem Yigit

🆕Our latest study is now out in Immunotherapy! 🧠The albumin–myosteatosis gauge (AMG) is an independent prognostic biomarker in ICI-treated patients 📉 Low AMG is associated with shorter PFS & OS 🎯A practical, accessible, and promising biomarker 🔗 doi.org/10.1080/175074…

📢Latest study from the Turkish Oncology Group Kidney Cancer Consortium just published! Grateful to all collaborators for their valuable contributions! The Oncologist Serhat Sekmek Uzm Dr Saadet Sim Yüksel Ürün deniztural #kidneycancer #Immunotherapy

Huge congrats Taha Koray Sahin ! Extremely happy to see your success as a humble and dedicated young scientist. Hard work paid-off! Can't wait to see what's next! OncoAlert Deniz Can Guven Sercan Aksoy, MD Ömer Dizdar #MedX #MedTwitter #CancerResearch

🎥 Can survivor stories heal distress? In Botswana, over 67% of breast cancer patients reported moderate-to-high distress. This pilot study found that peer-led survivor videos reduced distress and alleviated fear and body image concerns. ✅ Cultural relevance matters. 📉 29%

Dynamic duo Dr Galip Can Uyar and Osman Sütcüoğlu published this #supponc study in The Lancet Reg Health-Europe The combined #PROMISE 🤝#CTI score outperformed #PROMISE #GRIm or #CTI alone in predicting 90-day mortality for unplanned hospitalizations for #cancer pts. 🔗: thelancet.com/journals/lanep…

Extremely happy to share my insights about #kidneycancer at #ASCO25 for CURE Today and our patients! We have more hope on the horizon for kidney cancer! ASCO Toni Choueiri, MD Yüksel Ürün Dana-Farber Lank Center for Genitourinary Oncology Ankara Üniversitesi #CancerResearch #Oncology #Cancer

🚨Just weeks after #ASCO25, the latest highlights in genitourinary cancers are now available. The newly released The ASCO Post provides a quick and concise overview. 👀Take another look, this time from our perspective w/ Yüksel Ürün 👉bit.ly/46lgtHK ASCO

🎙️ I had the honor to join the #OpenDoorsPodcast hosted by Drs. Ioanna Nixon & Vilma Pacheco to share my journey in oncology from LATAM 🌎 We talked about challenges, #resilience, and the power of global #mentorship #ASCOIDEA #Wellbeing ⁦OncoDaily⁩ linkedin.com/posts/open-doo…

I'm thrilled to share our new meta-analysis! Primarily including CRC and pancreatic cancer patients, it shows that omitting 5-FU bolus from chemotherapy regimens maintains PFS and OS while reducing risks of G3-4 neutropenia and thrombocytopenia. tandfonline.com/doi/full/10.10…

Great to see fantastic fellows from Ankara Tıp Fakültesi presenting high-quality studies in #ESMOGI25 Erman Akkus Beliz Bahar Karaoğlan Special congrats to Beliz Bahar Karaoğlan for #MeritTravelGrant 👏👏 Thanks to ESMO - Eur. Oncology for supporting YOs, as always #ESMOYOC Emre Yekedüz Taha Koray Sahin Yakup Ergün

Inviting all Young Oncologists to #ESMOYOC sessions at #ESMOGI25 Starting today with Mentorship Session with three great speakers at 12:45 ESMO - Eur. Oncology OncoDaily Jakob Nikolas Kather Rodrigo Sánchez-Bayona Elene Mariamidze Liz Connolly Pawel Sobczuk Myrto K. Moutafi Hongcheng Zhu 祝鸿程 Saad Nasir, MD Pablo Mando

It couldn't be missed out! My dear friend Deniz Can Guven , a member of ESMO - Eur. Oncology #ESMOYOC , is chairing the great sessions for all young oncologists at #ESMOGI25 ! Rodrigo Sánchez-Bayona Yüksel Ürün OncoAlert Matteo Lambertini, MD PhD Erman Akkus Beliz Bahar Karaoğlan Ömer Dizdar Sercan Aksoy, MD

We continue #ESMOYOC activities at #ESMOGI25 today at 12:45pm ⏱️⏱️ We have 3️⃣ great speakers to discuss building a career in GI oncology 💯💯 Expecting all YOs to join for valuable insights ✅✅ ESMO - Eur. Oncology OncoDaily Arndt Vogel Rachel Riechelmann Josep Tabernero Rille

📌Our new study from the Turkish Oncology Group Kidney Cancer Consortium just published! 📌Uric acid level is prognostic factor for OS in patients with mRCC treated with Nivolumab Yüksel Ürün Emre Yekedüz Hatice Bölek

tandfonline.com/eprint/D7EVPHK… 🆕Our latest study is now out in Experts Review of Anti Cancer Therapy. 🧠ICIs appear safe in patients with chronic hepatitis B 📉 Of the 65 patients, 15 (23.0%) experienced irAEs of Grade 1–2. 1 (1.5%) patient had grade 3 pneumonitis